Simulations Plus (NASDAQ:SLP) Stock Rating Upgraded by StockNews.com

Simulations Plus (NASDAQ:SLP) was upgraded by stock analysts at StockNews.com from a “sell” rating to a “hold” rating in a report issued on Friday.

SLP has been the topic of a number of other reports. William Blair reaffirmed an “outperform” rating on shares of Simulations Plus in a report on Wednesday, January 8th. KeyCorp boosted their price target on Simulations Plus from $35.00 to $37.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Two investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Simulations Plus has a consensus rating of “Moderate Buy” and an average target price of $49.40.

Simulations Plus Price Performance

Shares of SLP traded up $1.86 on Friday, reaching $25.68. 647,171 shares of the stock traded hands, compared to its average volume of 175,152. The stock’s 50-day moving average price is $30.03 and its 200-day moving average price is $30.29. The firm has a market cap of $515.96 million, a price-to-earnings ratio of 64.20 and a beta of 0.89. Simulations Plus has a 12 month low of $22.87 and a 12 month high of $51.22.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.06. The firm had revenue of $22.43 million for the quarter, compared to analyst estimates of $21.93 million. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The business’s revenue for the quarter was up 22.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.20 EPS. As a group, equities research analysts forecast that Simulations Plus will post 1.09 earnings per share for the current fiscal year.

Insider Activity at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $33.91, for a total value of $678,200.00. Following the completion of the sale, the director now owns 3,402,584 shares in the company, valued at approximately $115,381,623.44. This trade represents a 0.58 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 19.40% of the company’s stock.

Institutional Trading of Simulations Plus

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Public Employees Retirement System of Ohio boosted its position in Simulations Plus by 58.6% in the 4th quarter. Public Employees Retirement System of Ohio now owns 41,692 shares of the technology company’s stock valued at $1,163,000 after buying an additional 15,399 shares during the last quarter. Millennium Management LLC boosted its holdings in Simulations Plus by 200.7% in the fourth quarter. Millennium Management LLC now owns 44,841 shares of the technology company’s stock valued at $1,251,000 after acquiring an additional 29,929 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Simulations Plus by 4.4% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,103 shares of the technology company’s stock valued at $254,000 after acquiring an additional 380 shares during the last quarter. Janus Henderson Group PLC increased its position in Simulations Plus by 7,753.3% in the fourth quarter. Janus Henderson Group PLC now owns 542,899 shares of the technology company’s stock worth $15,141,000 after purchasing an additional 535,986 shares during the period. Finally, Deutsche Bank AG raised its holdings in Simulations Plus by 52.9% during the 4th quarter. Deutsche Bank AG now owns 14,916 shares of the technology company’s stock worth $416,000 after purchasing an additional 5,160 shares during the last quarter. Institutional investors and hedge funds own 78.08% of the company’s stock.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.